1. 广东省中医院
2. 新疆维吾尔自治区乌鲁木齐中医医院
3. 湖南中医药大学第一附属医院
4. 武汉科技大学附属天佑医院
5. 山西省运城市中医院
6. 中国中药协会药物研究评价技术中心
7. 陕西中医药大学第二附属医院
8. 河南省郑州市中医院
9. 河南省开封市中心医院
10. 山东省枣庄市妇幼保健院
11. 新疆维吾尔自治区昌吉回族自治州中医医院
12. 河南省漯河市中医院
13. 贵州医科大学第二附属医院
纸质出版:2021
移动端阅览
[1]黄腾,王孟清,杜幼蕊,韩选明,王晓燕,孟永胜,张建红,鲁彩霞,冯自威,罗红芳,袁敏华,易文龙,高学敏,孙媛媛,许尤佳.枫蓼肠胃康颗粒治疗小儿急性腹泻(湿热泻)120例随机双盲多中心临床研究[J].中医杂志,2021,62(04):318-323.
HUANG Teng, WANG Mengqing, DU Yourui, et al. Fengliaochangweikang Granule (枫蓼肠胃康颗粒) for Infantile Acute Diarrhea with Damp-Heat Pattern: a Randomized, Double-blind, Multicenter Clinical Trial[J]. Journal of Traditional Chinese Medicine2021, 62(4): 318-323.
[1]黄腾,王孟清,杜幼蕊,韩选明,王晓燕,孟永胜,张建红,鲁彩霞,冯自威,罗红芳,袁敏华,易文龙,高学敏,孙媛媛,许尤佳.枫蓼肠胃康颗粒治疗小儿急性腹泻(湿热泻)120例随机双盲多中心临床研究[J].中医杂志,2021,62(04):318-323. DOI: 10.13288/j.11-2166/r.2021.04.010.
HUANG Teng, WANG Mengqing, DU Yourui, et al. Fengliaochangweikang Granule (枫蓼肠胃康颗粒) for Infantile Acute Diarrhea with Damp-Heat Pattern: a Randomized, Double-blind, Multicenter Clinical Trial[J]. Journal of Traditional Chinese Medicine2021, 62(4): 318-323. DOI: 10.13288/j.11-2166/r.2021.04.010.
目的评价枫蓼肠胃康颗粒治疗小儿急性腹泻(湿热泻)的临床有效性和安全性。方法采用随机、双盲、阳性药平行对照
多中心、非劣效试验设计。由全国12家医院共收集6个月~5岁患儿240例
随机分为对照组和治疗组各120例。对照组口服儿泻停颗粒
治疗组口服枫蓼肠胃康颗粒
两组均每日3次
共治疗5天
比较两组患儿5天止泻率、3天止泻率、治疗满3天大便次数及性状复常率、止泻时间、中医证候积分有效率及用药安全性。结果治疗组5天止泻率为87.29%
对照组为84.62%
差异无统计学意义(P>0.05);通过非劣分析显示
治疗组与对照组差值的95%CI(-0.0621
0.1155)
95%CI区间下限值大于非劣介值-0.15
提示治疗组非劣于对照组成立。治疗组和对照组3天止泻率分别为60.50%、48.72%
差异无统计学意义(P>0.05)。两组大便次数及性状复常率差异无统计学意义(P>0.05)。治疗组和对照组中位止泻时间分别为92h、96h。两组中医证候积分及中医证候积分有效率比较差异无统计学意义。治疗期间治疗组未发生不良反应
对照组发生丙氨酸氨基转移酶升高、门冬氨酸氨基转移酶升高各1例次
组间不良反应发生率比较差异无统计学意义(P>0.05)。结论枫蓼肠胃康对6个月~5岁小儿急性腹泻(湿热泻)止泻率与儿泻停颗粒疗效相当且起效较快
临床应用安全。
Objective To evaluate the effectiveness and safety of Fengliaochangweikang Granule(枫蓼肠胃康颗粒) in the treatment of infantile acute diarrhea with damp-heat pattern. Methods A randomized
double-blind
multicenter clinical trial was conducted
and the non-inferiority design was used. A total of 240 children at the age of six months to five years old were recruited from 12 hospitals in China
and they were randomly divided to either receive Fengliaochangweikang Granule(treatment group) or Er Xie Ting Granule(儿泻停颗粒
control group)
with 120 patients in each group. Both groups were treated threee times a day for five days. The 5-day diarrhea disappearance rate
3-day diarrhea disappearance rate
3-day normalization rate of defecation frequency and stool characteristics
duration of diarrhea
the effectiveness rate based on traditional Chinese medicine(TCM) syndrome scores
and safety outcomes were assessed. Results The 5-day diarrhea disappearance rate of the treatment group was 87.29% while that of the control group was 84.62%(P>0.05); the lower limit of 95% confidence interval(CI)(-0.0621
0.1155)was greater than the non-inferior margin-0.15
accepting that assumption that the treatment group was not inferior to the control. There were no significant differences between the treatment group(60.50%) and the control(48.72%) in the 3-day diarrhea disappearance rate(P>0.05)
and in the normalization rate of defecation frequency and stool characteristics(P>0.05). The median duration of diarrhea stop in the treatment group and the control group was 92 hours and 96 hours respectively. The effectiveness rate based on TCM syndrome scores was not statistically different between groups. There were no adverse events in the treatment group
while one each case of elevated alanine aminotransferase and elevated aspartate aminotransferase appeared in the control group(P>0.05). Conclusion Fengliaochangweikang Granule is not inferior to Er Xie Ting Granule in improving the diarrhea disappearance rate for children at the age of six months to five years with acute diarrhea of damp-heat pattern
and is found to be safe.
0
浏览量
61
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号